• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec4
Galmed Pharmaceuticals Grants New Use Patent for ARAMCHOL in Combination with Madrigal Pharmaceuticals' REZDIFFRA
13:35
Nov27
Galmed Pharma released FY2025 Q3 earnings on November 26 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3464 (forecast USD -0.54)
04:00
Galmed Pharma released FY2025 9 Months Earnings on November 26 Post-Market (EST), Actual Revenue USD 0, Actual EPS USD -1.5987
04:00
Oct29
Galmed Pharmaceuticals Annual General Meeting Proposals Passed
20:36
Aug29
Galmed Pharma released FY2025 Q2 earnings on August 28 (EST), actual revenue USD 0, actual EPS USD -0.6319 (forecast EPS USD -0.83)
03:00
Galmed Pharma released FY2025 Semi-Annual Earnings on August 28 (EST), actual revenue USD 0, actual EPS USD -1.2554
03:00

Schedules & Filings

Schedules
Filings
Nov26
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.892 M, EPS -0.3464

Aug28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.495 M, EPS -0.6319

May22
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.104 M, EPS -0.6203

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
NVDA
183.380
0.00%
0.000
AAPL
280.700
0.00%
0.000
GOOG
318.390
0.00%
0.000
GOOGL
317.620
0.00%
0.000
MSFT
480.840
0.00%
0.000
VTI
337.090
0.00%
0.000
AMZN
229.110
0.00%
0.000
AVGO
381.030
0.00%
0.000
VOO
629.300
0.00%
0.000
META
661.530
0.00%
0.000
View More